Erlotinib Glenmark

Erlotinib Glenmark is a medication used to treat certain types of cancer. This oral medication is manufactured by Glenmark Arzneimittel Gmbh and is designed for targeted therapy.

Erlotinib Glenmark is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by targeting specific proteins involved in cancer cell growth. Patients often wonder, 'What is Erlotinib used for?' This medication is part of a class of drugs known as tyrosine kinase inhibitors, which help to slow the progression of cancer by interfering with the growth and spread of cancer cells.

Common effects of Erlotinib Glenmark may include skin rash, diarrhea, and fatigue. Some patients may also experience appetite loss and nausea. These effects can vary in severity and may not affect everyone who takes the medication.

Erlotinib Glenmark should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Erlotinib Glenmark may interact with certain medications, including those that are metabolized by the liver. It is important to discuss all current medications with a healthcare provider to ensure safe use. Additionally, patients should avoid grapefruit and grapefruit juice, as they can affect the metabolism of Erlotinib.